Theatre

Genentech defends breast cancer drug a decade after Avastin drama

www.bizjournals.com

Genentech Inc. likely will get another chance to build the scientific proof that its drug targeting a type of breast cancer actually extends patients' lives.

Read more

Related Articles

Back to top button